Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 25,863 | 8,974 | 32,923 | 23,305 | 10,662 |
Marketable Securities | N/A | 15,747 | N/A | N/A | N/A |
Receivables | 11 | 401 | 691 | 67 | 1,559 |
TOTAL | $28,279 | $27,448 | $35,829 | $25,184 | $14,266 |
Non-Current Assets | |||||
PPE Net | 209 | 274 | 313 | 177 | 224 |
Other Non-Current Assets | 270 | 995 | 466 | 278 | 325 |
TOTAL | $479 | $1,269 | $779 | $455 | $548 |
Total Assets | $28,758 | $28,717 | $36,608 | $25,639 | $14,814 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 2,646 | 2,808 | 1,586 | 1,347 | 2,391 |
Other current liabilities | 394 | 61 | 326 | 489 | 7,051 |
TOTAL | $3,139 | $3,035 | $2,146 | $2,022 | $9,698 |
Non-Current Liabilities | |||||
Other Non-Current Liabilities | 5,200 | 5,298 | 5,658 | 5,139 | 5,197 |
TOTAL | $5,200 | $5,298 | $5,658 | $5,139 | $5,197 |
Total Liabilities | $8,339 | $8,332 | $7,804 | $7,161 | $14,896 |
Shareholders' Equity | |||||
Common Shares | 319,215 | 310,788 | 312,257 | 266,369 | 234,428 |
Retained earnings | -330,399 | -321,719 | -313,906 | -274,049 | -259,695 |
Other shareholders' equity | 403 | 509 | 3,196 | 2,999 | 3,076 |
TOTAL | $20,419 | $20,385 | $28,803 | $18,478 | $-81 |
Total Liabilities And Equity | $28,758 | $28,717 | $36,608 | $25,639 | $14,814 |